GlassScriptPhysician profile
Jose M Diaz
NPI 1427078781
$2,216.89
in general payments reported to CMS, 2019-2025
25 companies · $494 in 2025
The $494 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $218 · 2021: $359 · 2022: $71.28 · 2023: $126 · 2024: $610 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,230.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $457.07 | 2019-2022 | |
| Novo Nordisk INC | $422.99 | 2019-2025 | Wegovy |
| Glaxosmithkline, LLC. | $260.21 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $149.46 | 2024-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $149.45 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $136.71 | 2024 | Nuplazid |
| Astrazeneca Pharmaceuticals LP | $109.20 | 2020-2025 | Farxiga |
| Sumitomo Pharma America, INC. | $92.44 | 2023-2025 | Gemtesa, Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $75.58 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.78 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $57.11 | 2023-2024 | Linzess |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.71 | 2024-2025 | Jardiance |
| Cranial Technologies, INC | $35.40 | 2023-2024 | Doc Band |
| Kowa Pharmaceuticals America, INC. | $34.08 | 2025 | Zoryve |
| Karyopharm Therapeutics INC. | $25.40 | 2024 | Xpovio |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $25.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.80 | 2023 | |
| Organon LLC | $19.79 | 2021-2023 | |
| Exact Sciences Corporation | $15.71 | 2024 | Cologuard Collection Kit |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.